Akari Therapeutics (AKTX) Depreciation and Depletion (2014 - 2016)
Akari Therapeutics recorded quarterly Depreciation and Depletion of $8436.0 in Q4 2016, down 12.82% quarter-over-quarter from $9677.0 in Q3 2016, and up 222.48% year-over-year from $2616.0 in Q1 2016.
Akari Therapeutics' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $8436.0 for Q4 2016.
- In Q4 2016, Depreciation and Depletion rose 222.48% year-over-year to $8436.0; the TTM figure through Dec 2016 stood at $36898.0 (up 424.12% YoY), while the FY2020 annual figure was $5013.0, down 67.47% from the prior year.
- Depreciation and Depletion came in at $8436.0 for Q4 2016 at Akari Therapeutics, down from $9677.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $10191.0 in Q2 2016 to a low of $764.0 in Q1 2015.
- A 3-year average of $4698.9 and a median of $2704.5 in 2015 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion surged 63.91% in 2015 and surged 1075.43% in 2016, its largest moves.
- Akari Therapeutics' Depreciation and Depletion stood at $1596.0 in 2014, then soared by 63.91% to $2616.0 in 2015, then soared by 222.48% to $8436.0 in 2016.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $8436.0, $9677.0, and $10191.0 for Q4 2016, Q3 2016, and Q2 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 8,436.00 |
| Dec 31, 2016 | 8,436.00 |
| Sep 30, 2016 | 9,677.00 |
| Sep 30, 2016 | 9,677.00 |
| Jun 30, 2016 | 10,191.00 |
| Jun 30, 2016 | 10,191.00 |
| Mar 31, 2016 | 8,594.00 |
| Mar 31, 2016 | 8,594.00 |
| Dec 31, 2015 | 2,616.00 |
| Dec 31, 2015 | 2,616.00 |
| Sep 30, 2015 | 2,793.00 |
| Sep 30, 2015 | 2,793.00 |
| Jun 30, 2015 | 867.00 |
| Jun 30, 2015 | 867.00 |
| Mar 31, 2015 | 764.00 |
| Mar 31, 2015 | 764.00 |
| Dec 31, 2014 | 1,596.00 |
| Dec 31, 2014 | 1,596.00 |
| Sep 30, 2014 | 1,455.00 |
| Sep 30, 2014 | 1,455.00 |